---

---

entities : Innate pharma s.a.    symbols : Nvo   

save search

---

Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 27.46% | O: 0.91% H: 0.72% C: 0.11%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -2.07% | O: 0.45% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| 0.41% | O: 13.88% H: 0.0% C: -3.58%
pharma natural cell sanofi

---

Innate Pharma Announces Conference Call and Webcast for Full Year 2022 Financial Results
Published: 2023-03-16 (Crawled : 07:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -0.64% | O: -0.07% H: 1.96% C: 0.56%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| -10.51% | O: -1.4% H: 0.03% C: -0.08%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 0.71% | O: 1.01% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| -20.35% | O: -6.11% H: 3.54% C: 0.69%
pharma conference year financial

---

Innate Pharma Provides Update on Silicon Valley Bank Exposure
Published: 2023-03-13 (Crawled : 09:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| -10.71% | O: -0.02% H: 1.44% C: -0.51%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -0.67% | O: -0.81% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| -16.47% | O: 2.21% H: 4.65% C: -1.66%
pharma update

---

Number of Shares and Voting Rights of Innate Pharma as of February 1, 2023
Published: 2023-02-21 (Crawled : 10:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| -10.92% | O: 0.55% H: 0.77% C: 0.14%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 0.19% | O: 0.79% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| -22.88% | O: -3.76% H: 0.0% C: -0.65%
pharma

---

Innate Pharma to Participate in Upcoming Investor Conferences - February 07, 2023
Published: 2023-02-07 (Crawled : 10:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 1.21% | O: -1.0% H: 0.0% C: 0.0%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| -8.63% | O: 0.19% H: 1.01% C: 0.91%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 4.17% | O: 1.64% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| -27.65% | O: -0.74% H: 2.52% C: 1.33%
pharma

---

Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers
Published: 2023-01-25 (Crawled : 07:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -4.4% | O: -0.92% H: 1.41% C: 1.41%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| -9.82% | O: -1.97% H: 1.74% C: 1.28%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -2.18% | O: 0.39% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| -32.04% | O: -0.28% H: 1.66% C: -0.28%
clearance expansion pharma collaboration sanofi

---

Press Release: Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology
Published: 2022-12-19 (Crawled : 07:00) - globenewswire.com
IPHYF | $2.65 104.6% 300 |

Health Technology

| 21.31% | O: 21.77% H: 0.0% C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 1.9% | O: 1.54% H: 0.51% C: -0.25%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| -5.27% | O: -1.82% H: 0.23% C: -0.11%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 2.03% | O: 1.14% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| 29.47% | O: 35.79% H: 10.85% C: 2.71%
pharma collaboration natural therapeutics sanofi

---

Number of Shares and Voting Rights of Innate Pharma as of December 1, 2022
Published: 2022-12-09 (Crawled : 07:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -1.1% | O: -0.89% H: 0.0% C: 0.0%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| -1.28% | O: 1.97% H: 0.41% C: -1.07%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 1.31% | O: -0.15% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| 20.0% | O: 3.41% H: 2.83% C: 0.0%
pharma

---

Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022
Published: 2022-12-01 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300 |

Health Technology

| 21.07% | O: 5.99% H: 0.0% C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 4.16% | O: 2.64% H: 2.88% C: 2.88%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 1.25% | O: 1.25% H: 0.2% C: -0.02%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 6.5% | O: 2.96% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| 14.42% | O: 4.56% H: 1.86% C: 1.86%
iph5201 pharma

---

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2022 Business Update
Published: 2022-11-07 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 7.92% | O: -2.01% H: 0.88% C: 0.88%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 12.23% | O: 0.91% H: 1.82% C: 1.43%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 9.57% | O: -0.46% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| 13.36% | O: -1.38% H: 2.8% C: 1.87%
pharma conference update

---

Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022
Published: 2022-11-04 (Crawled : 10:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 8.36% | O: -0.02% H: 0.43% C: 0.43%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 10.79% | O: -0.25% H: 0.11% C: -1.03%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 11.82% | O: 2.05% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| 16.04% | O: -4.27% H: 8.9% C: 6.93%
pharma trial results platform

---

Innate Pharma to Participate in Upcoming Investor Conferences - November 02, 2022
Published: 2022-11-02 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 5.38% | O: -2.21% H: 0.0% C: -0.14%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 18.54% | O: 4.84% H: 4.18% C: 1.48%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 9.83% | O: 0.07% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| 12.33% | O: -5.48% H: 2.42% C: -0.97%
pharma

---

Innate Pharma 2023 Financial Calendar
Published: 2022-10-20 (Crawled : 07:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 20.6% | O: -0.35% H: 1.28% C: -0.17%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 18.6% | O: -1.19% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| 18.27% | O: 0.0% H: 2.4% C: 1.92%
pharma financial

---

Innate Pharma 2023 Financial Calendar Innate Pharma SA released its 2023 financial calendar. argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022 argenx announc...
Published: 2022-10-20 (Crawled : 07:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 20.6% | O: -0.35% H: 1.28% C: -0.17%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 18.6% | O: -1.19% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| 18.27% | O: 0.0% H: 2.4% C: 1.92%
DNLI | $15.56 -3.41% -3.6% 940K |

Health Technology

| -44.17% | O: -5.24% H: 10.87% C: 5.45%
pharma report financial update results

---

Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Mycosis Fungoides
Published: 2022-09-23 (Crawled : 06:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 23.68% | O: 5.45% H: 0.0% C: -8.46%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 28.33% | O: -0.53% H: 0.81% C: 0.14%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 21.53% | O: -1.69% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| -0.4% | O: -2.02% H: 0.41% C: -3.72%
ongoing pharma trial phase 2

---

Innate Pharma Reports First Half 2022 Financial Results and Business Update
Published: 2022-09-15 (Crawled : 06:00) - biospace.com/
BNPQF | News | $70.45 2.76% -13.4% 0 |

Finance

| 40.23% | O: -1.65% H: 0.0% C: -2.85%
BNPQY | News | $36.5 0.11% -2.68% 94K |

Finance and Insurance

| 45.53% | O: -1.12% H: 2.34% C: 1.69%
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 12.31% | O: 1.6% H: 0.0% C: -6.5%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 20.11% | O: -0.88% H: 0.45% C: -0.87%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 17.55% | O: 0.4% H: 0.84% C: 0.37%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| 0.0% | O: 3.25% H: 0.0% C: 0.0%
pharma financial update results

---

Innate Pharma Announces Conference Call and Webcast for First Half 2022 Business Update
Published: 2022-09-08 (Crawled : 06:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 22.46% | O: -0.65% H: 0.0% C: 0.0%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 20.35% | O: -0.72% H: 1.61% C: 1.55%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 18.52% | O: -0.47% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| -5.02% | O: 1.54% H: 0.76% C: -1.52%
pharma conference update

---

Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022
Published: 2022-09-05 (Crawled : 08:00) - biospace.com/
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| Email alert Add to watchlist
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| Email alert Add to watchlist
IPHYF | $2.65 104.6% 300 |

Health Technology

| Email alert Add to watchlist
pharma platform phase 2b

---

Innate Pharma to Participate in Upcoming Investor Conferences - Aug 23, 2022
Published: 2022-08-23 (Crawled : 07:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 12.52% | O: 1.75% H: 0.0% C: 0.0%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 17.3% | O: -0.86% H: 0.4% C: -0.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 15.07% | O: -0.72% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| -6.82% | O: 1.52% H: 2.05% C: 0.75%
pharma

---

Innate Pharma Provides Update on AstraZeneca-Sponsored INTERLINK-1 Phase 3 Study
Published: 2022-08-01 (Crawled : 10:00) - biospace.com/
IPHYF | $2.65 104.6% 300 |

Health Technology

| -16.14% | O: -14.87% H: 4.09% C: 4.09%
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -6.88% | O: -3.9% H: 0.0% C: 0.0%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 7.65% | O: -0.21% H: 0.41% C: -0.73%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -5.07% | O: -1.92% H: 0.0% C: 0.0%
IPHA | $2.46 3.8% 4.05% 690 |

Health Technology

| -23.12% | O: -11.25% H: 0.0% C: -1.06%
AZN | News | $71.2 0.49% 0.46% 5.4M |

Health Technology

| 7.5% | O: 0.44% H: 0.53% C: -1.31%
pharma update study

---

Gainers vs Losers

61%

39%

Top 10 Gainers

CSSE 4 | $0.4253 179.25% 64.77% 210M |

Consumer Services

BOF | $2.08 77.78% 41.21% 110M |

ILAG | $0.54 12.27% 40.62% 3.7M |

LICN | $0.999 78.39% 40.49% 15M |

AMST | $3.4 70.0% 39.58% 70M |

Technology Services

MTC | $3.6 60.71% 38.04% 9.1M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.458 14.5% 30.92% 91K |

Health Services

WHLM | $6.25 35.87% 28.46% 700K |

Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M |

Information

---

Your saved searches

---